He is a graduate of Northwestern University's Medill School of Journalism and a former Fulbright scholar. Jeff appears regularly on television and radio and teaches political journalism at Georgetown University. Jeff began his career in Frankfurt, Germany as a business reporter before being posted to Brussels, Belgium, where he covered the European Union. Biden's promise on March 2 that there would be enough COVID-19 vaccines for every adult in the United States by the end of May, he. He is a winner of the WHCA's “Excellence in Presidential News Coverage Under Deadline Pressure" award and co-winner of the Association for Business Journalists' "Breaking News" award. Defense Production Act Hastens COVID-19 Vaccine Production. His and the WHCA's work was recognized with Deutsche Welle's "Freedom of Speech Award." Jeff has asked pointed questions of domestic and foreign leaders, including Russian President Vladimir Putin and North Korea's Kim Jong Un. He served as president of the White House Correspondents’ Association in 2016-2017, leading the press corps in advocating for press freedom in the early days of the Trump administration. Vaccines Europe, is a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional.
He has covered the presidencies of Barack Obama, Donald Trump and Joe Biden and the presidential campaigns of Biden, Trump, Obama, Hillary Clinton and John McCain. Jeff Mason is a White House Correspondent for Reuters. He also said 2.6 million kids aged 5-11 will have received their first shot of the COVID-19 vaccine by the end of Wednesday. Zients said 80% of Americans 12 and older have received at least one COVID-19 vaccine dose, highlighting a milestone in efforts to curb the spread of the deadly virus. In the long term, it would help establish sustained domestic manufacturing capacity to rapidly produce vaccines for future threats, Zients said. In the short term, the program would make a significant amount of COVID-19 vaccine doses available at cost for global use. It will be paid for with funds from the American Rescue Plan Biden signed into law in March. The investment in vaccine production is part of a private-public partnership to address vaccine needs at home and around the world and to prepare for future pandemics, he said. Production will start in the second half of 2022, he said. Pfizer/BioNTech and Moderna are the only makers of mRNA vaccines, though Zients said subcontractors of those companies would also be included. Zients said the government was preparing to offer makers of the mRNA vaccines substantial help to expand infrastructure and capacity, including facilities, equipment, staff or training. doi:10.WASHINGTON, Nov 17 (Reuters) - The United States plans to invest billions of dollars in expanding COVID-19 vaccine manufacturing capacity and make available an additional one billion doses per year, White House COVID-19 coordinator Jeff Zients said on Wednesday.Īctivists have pressured President Joe Biden's administration to increase vaccine supply to poorer countries. Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: Two case reports. Mohamed L, Madsen AMR, Schaltz-Buchholzer F, Ostenfeld A, Netea MG, Benn CS, Kofoed PE. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Schildknecht KR, Pratt RH, Feng PI, Price SF, Self JL. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. TB information for international travelers fact sheet. Centers for Disease Control and Prevention.
Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force, Mangione CM, Barry MJ, et al.
0 kommentar(er)
